Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Research

The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis

Authors: Liu-qing Zhou, Yao Hu, Hong-jun Xiao

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

Survivin has been recently identified as a promising novel therapeutic target and prognostic marker in different types of cancer. Here we conducted a comprehensive meta-analysis to better clarify they the precise prognostic and diagnostic value of survivin in head and neck squamous cell carcinoma (HNSCC).

Methods

Database of PubMed (Medline), Embase, and Web of Science were systematically searched for related published literature up to September 2020. Pooled hazards ratios (HR) and related 95% confidence intervals (CI) were used to estimate the association of survivin expression and survival outcomes in HNSCC patients.

Results

Twenty eight studies with 4891 patients were finally included in this meta-analysis, the pooled analysis indicated that the survivin expression was significantly correlated with poorer overall survival (OS) (HR, 2.02; 95% CI, 1.65–2.47, P < 0.001), and poorer disease-free survival (DFS)/ disease-specific survival (DSS) (HR = 2.03, 95%CI: 1.64–2.52, P < 0.001; HR = 1.92, 95%CI: 1.41–2.60, P < 0.001, receptively). Similar results were observed in subgroup analysis stratified by different cancer types, such as laryngeal squamous cell carcinoma (LSCC) (HR = 1.35, 95%CI: 1.05–1.74, P < 0.001), oral squamous cell carcinomas (OSCC) (HR = 2.45, 95%CI: 1.89–3.17, P < 0.001), nasopharyngeal carcinoma (NPC) (HR = 2.53, 95%CI: 1.76–3.62, P < 0.001) and HNSCC (HR = 1.52, 95%CI: 1.25–1.86, P < 0.001). Furthermore, ethnicity-stratified analysis indicated that survivin was significantly associated with poorer OS among both Asian and Non- Asian HNSCC patients (HR = 2.16, 95%CI: 1.76–2.66; HR = 1.56, 95%CI: 1.33–1.82, respectively).

Conclusions

Our results suggested that survivin is predictors of worse prognosis in HNSCC patients. Hence, survivin is a potential therapeutic target for HNSCC.
Appendix
Available only for authorised users
Literature
4.
go back to reference Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004;15(8):1179–86. https://doi.org/10.1093/annonc/mdh308.CrossRefPubMed Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004;15(8):1179–86. https://​doi.​org/​10.​1093/​annonc/​mdh308.CrossRefPubMed
12.
go back to reference Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000. Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.
15.
go back to reference Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints by M. Parmar, V. Torri and L. Stewart, Statistics in Medicine 1998; 17: 2815–2834 (p 1817). Statistics in Medicine, 2010. 23(11): p. 1817–1817. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints by M. Parmar, V. Torri and L. Stewart, Statistics in Medicine 1998; 17: 2815–2834 (p 1817). Statistics in Medicine, 2010. 23(11): p. 1817–1817.
17.
go back to reference Ben Elhadj M, et al. Expression Profile of Survivin and p16 in Laryngeal Squamous Cell Carcinoma: Contribution of Tunisian Patients. Ear Nose Throat J. 2021;100(1):NP7-15. Ben Elhadj M, et al. Expression Profile of Survivin and p16 in Laryngeal Squamous Cell Carcinoma: Contribution of Tunisian Patients. Ear Nose Throat J. 2021;100(1):NP7-15.
22.
go back to reference Li DW, et al. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma. Med Oncol. 2011;28(Suppl 1):S333–40.CrossRefPubMed Li DW, et al. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma. Med Oncol. 2011;28(Suppl 1):S333–40.CrossRefPubMed
31.
go back to reference Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res. 2002;22(4):2377–83.PubMed Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res. 2002;22(4):2377–83.PubMed
34.
go back to reference Farnebo L, Tiefenböck K, Ansell A, Thunell LK, Garvin S, Roberg K. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. Int J Cancer. 2013;133(8):1994–2003. https://doi.org/10.1002/ijc.28200.CrossRefPubMed Farnebo L, Tiefenböck K, Ansell A, Thunell LK, Garvin S, Roberg K. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. Int J Cancer. 2013;133(8):1994–2003. https://​doi.​org/​10.​1002/​ijc.​28200.CrossRefPubMed
39.
go back to reference Su L, et al. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(4):484–91.CrossRefPubMed Su L, et al. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(4):484–91.CrossRefPubMed
40.
go back to reference Troiano G, et al. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(9):2664. Troiano G, et al. Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(9):2664.
42.
go back to reference Marioni G, Staffieri A, Lionello M, Tealdo G, Staffieri C, Giacomelli L, et al. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study. J Oral Pathol Med. 2013;42(4):339–44. https://doi.org/10.1111/jop.12020.CrossRefPubMed Marioni G, Staffieri A, Lionello M, Tealdo G, Staffieri C, Giacomelli L, et al. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study. J Oral Pathol Med. 2013;42(4):339–44. https://​doi.​org/​10.​1111/​jop.​12020.CrossRefPubMed
44.
go back to reference Kim YH, et al. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med. 2010;39(5):368–75.PubMed Kim YH, et al. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med. 2010;39(5):368–75.PubMed
47.
go back to reference Yilmaz A, Malya F, Ozturk G, Citgez B, Ozdenkaya Y, Ersavas C, et al. Effect of pre-operative red blood cell distribution on cancer stage and morbidity rate in patients with pancreatic cancer. Int J Clin Exp Med. 2014;7(9):3072–5.PubMedPubMedCentral Yilmaz A, Malya F, Ozturk G, Citgez B, Ozdenkaya Y, Ersavas C, et al. Effect of pre-operative red blood cell distribution on cancer stage and morbidity rate in patients with pancreatic cancer. Int J Clin Exp Med. 2014;7(9):3072–5.PubMedPubMedCentral
54.
go back to reference Santarelli A, et al. Survivin-Based Treatment Strategies for Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(4):971. Santarelli A, et al. Survivin-Based Treatment Strategies for Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(4):971.
Metadata
Title
The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis
Authors
Liu-qing Zhou
Yao Hu
Hong-jun Xiao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08170-3

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine